company background image
1701 logo

China Chemical & Pharmaceutical TWSE:1701 Stock Report

Last Price

NT$22.30

Market Cap

NT$6.6b

7D

0.2%

1Y

-13.7%

Updated

13 Jun, 2024

Data

Company Financials

China Chemical & Pharmaceutical Co., Ltd.

TWSE:1701 Stock Report

Market Cap: NT$6.6b

China Chemical & Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Chemical & Pharmaceutical
Historical stock prices
Current Share PriceNT$22.30
52 Week HighNT$26.80
52 Week LowNT$21.20
Beta0.13
1 Month Change0.22%
3 Month Change-1.76%
1 Year Change-13.73%
3 Year Change-7.47%
5 Year Change16.75%
Change since IPO-35.24%

Recent News & Updates

Recent updates

Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

Apr 25
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

Apr 07
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

Mar 17
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 24
China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Jan 27
Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

Jan 06
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

Dec 16
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Nov 26
China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Shareholder Returns

1701TW PharmaceuticalsTW Market
7D0.2%0.1%2.5%
1Y-13.7%6.5%26.3%

Return vs Industry: 1701 underperformed the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 1701 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 1701's price volatile compared to industry and market?
1701 volatility
1701 Average Weekly Movement1.9%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1701 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1701's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1952n/aChih-Yung Wuwww.ccpc.com.tw

China Chemical & Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. The company provides sexual function supplements; cardiovascular drugs, anti-lipidemia drugs, and peripheral circulation impediment relieving agents; diabetes treatment drugs, adrenocortico steroids, and weight control drugs; and anti-infection drugs, such as antibiotics, antifungal drugs, and anti-viral drugs.

China Chemical & Pharmaceutical Co., Ltd. Fundamentals Summary

How do China Chemical & Pharmaceutical's earnings and revenue compare to its market cap?
1701 fundamental statistics
Market capNT$6.64b
Earnings (TTM)NT$327.98m
Revenue (TTM)NT$8.76b

20.2x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1701 income statement (TTM)
RevenueNT$8.76b
Cost of RevenueNT$5.55b
Gross ProfitNT$3.21b
Other ExpensesNT$2.88b
EarningsNT$327.98m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.10
Gross Margin36.61%
Net Profit Margin3.74%
Debt/Equity Ratio41.8%

How did 1701 perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

45%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.